---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-25-002010"
form_type: "8-K"
ticker: "VNRX"
cik: "0000093314"
company_name: "VOLITIONRX LTD"
filed_at: "2025-03-26T23:59:59+00:00"
generated_at: "2026-05-24T05:24:22.871966+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# VolitionRx announces $2.3M registered direct offering; insiders buy 2.36M shares at $0.55

## Summary
- 2,363,636 shares sold to insiders (directors, officers, existing stockholders) at $0.55/share.
- 1,739,087 shares + warrants (exercise $0.66, 5-year) sold to other investors at $0.55 combined.
- Gross proceeds $2.3M upfront; up to $1.1M additional if warrants fully exercised.
- Net proceeds for R&D, clinical studies, product commercialization, and working capital.

## SEC filing metadata
- accession: 0001477932-25-002010
- form_type: 8-K
- ticker: VNRX
- cik: 0000093314
- company_name: VOLITIONRX LTD
- filed_at: 2025-03-26T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/93314/000147793225002010/0001477932-25-002010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/93314/000147793225002010/vnrx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-25-002010
- JSON: https://secwatch.observer/filing/0001477932-25-002010.json
- Plain text: https://secwatch.observer/filing/0001477932-25-002010.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.